These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 31873147

  • 1. Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies.
    Chae W, Kim P, Kim H, Cheong YC, Kim YS, Kang SM, Seong BL.
    Sci Rep; 2019 Dec 23; 9(1):19675. PubMed ID: 31873147
    [Abstract] [Full Text] [Related]

  • 2. Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
    Chae W, Kim P, Hwang BJ, Seong BL.
    Vaccine; 2019 Mar 07; 37(11):1457-1466. PubMed ID: 30765169
    [Abstract] [Full Text] [Related]

  • 3. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J, Vandenberg K, Laurie K, Barr IG, Zhang Y, Rockman S.
    Front Immunol; 2023 Mar 07; 14():1147028. PubMed ID: 37033922
    [Abstract] [Full Text] [Related]

  • 4. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S, Soto J, Vasudevan A, Schmeisser F, Alvarado-Facundo E, Wang W, Weiss CD, Weir JP.
    PLoS One; 2017 Mar 07; 12(4):e0175733. PubMed ID: 28423025
    [Abstract] [Full Text] [Related]

  • 5. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
    Vasudevan A, Woerner A, Schmeisser F, Verma S, Williams O, Weir JP.
    Influenza Other Respir Viruses; 2018 Mar 07; 12(2):250-258. PubMed ID: 29152878
    [Abstract] [Full Text] [Related]

  • 6. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.
    Schmeisser F, Vasudevan A, Soto J, Kumar A, Williams O, Weir JP.
    Influenza Other Respir Viruses; 2014 Sep 07; 8(5):587-95. PubMed ID: 25087462
    [Abstract] [Full Text] [Related]

  • 7. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.
    J Virol Methods; 2011 Dec 07; 178(1-2):129-36. PubMed ID: 21907241
    [Abstract] [Full Text] [Related]

  • 8. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
    Schmeisser F, Jing X, Joshi M, Vasudevan A, Soto J, Li X, Choudhary A, Baichoo N, Resnick J, Ye Z, McCormick W, Weir JP.
    Influenza Other Respir Viruses; 2016 Mar 07; 10(2):134-40. PubMed ID: 26616263
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.
    de Vries RD, Nieuwkoop NJ, Krammer F, Hu B, Rimmelzwaan GF.
    Virus Res; 2020 Feb 07; 277():197839. PubMed ID: 31837382
    [Abstract] [Full Text] [Related]

  • 10. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y, Han L, Palladino G, Ferrari A, Xie Y, Carfi A, Dormitzer PR, Settembre EC.
    Vaccine; 2015 Oct 05; 33(41):5342-5349. PubMed ID: 26348403
    [Abstract] [Full Text] [Related]

  • 11. Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies.
    Ferrara F, Del Rosario JMM, da Costa KAS, Kinsley R, Scott S, Fereidouni S, Thompson C, Kellam P, Gilbert S, Carnell G, Temperton N.
    Front Immunol; 2021 Oct 05; 12():661379. PubMed ID: 34108964
    [Abstract] [Full Text] [Related]

  • 12. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC.
    Vaccine; 2016 Jun 17; 34(29):3388-95. PubMed ID: 27154389
    [Abstract] [Full Text] [Related]

  • 13. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W, Wang S, Chen H, Ren H, Huang X, Wang G, Chen Z, Chen L, Chen Z, Zhou P.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28179535
    [Abstract] [Full Text] [Related]

  • 14. An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.
    Rajendran M, Sun W, Comella P, Nachbagauer R, Wohlbold TJ, Amanat F, Kirkpatrick E, Palese P, Krammer F.
    PLoS One; 2018 May 01; 13(4):e0194830. PubMed ID: 29617394
    [Abstract] [Full Text] [Related]

  • 15. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y, Palladino G, Xie Y, Ferrari A, Settembre EC.
    Vaccine; 2018 May 17; 36(21):3010-3017. PubMed ID: 29680201
    [Abstract] [Full Text] [Related]

  • 16. N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing.
    An Y, Parsons LM, Jankowska E, Melnyk D, Joshi M, Cipollo JF.
    J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30355697
    [Abstract] [Full Text] [Related]

  • 17. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.
    Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG, Rockman S.
    Influenza Other Respir Viruses; 2013 Mar 15; 7(2):191-200. PubMed ID: 22583601
    [Abstract] [Full Text] [Related]

  • 18. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
    Nakajima R, Supnet M, Jasinskas A, Jain A, Taghavian O, Obiero J, Milton DK, Chen WH, Grantham M, Webby R, Krammer F, Carter D, Felgner PL, Davies DH.
    mSphere; 2018 Dec 12; 3(6):. PubMed ID: 30541779
    [Abstract] [Full Text] [Related]

  • 19. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.
    Khurana S, King LR, Manischewitz J, Coyle EM, Golding H.
    Vaccine; 2014 Apr 17; 32(19):2188-97. PubMed ID: 24613520
    [Abstract] [Full Text] [Related]

  • 20. Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay.
    Lorbetskie B, Cunningham AM, Lemieux M, Durno L, Farnsworth A, Wang J, Li C, Li X, Gilbert M, Sauvé S, Girard M.
    Anal Chem; 2019 Jul 16; 91(14):8908-8917. PubMed ID: 31251585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.